Larson Financial Group’s AgomAb Therapeutics NV AGMB Stock Holding History
Bought
Maintained
Sold
Other funds holding AGMB
SL
Larson Financial Group's AGMB Position: Q3 2026 in Review
Larson Financial Group sold out of AgomAb Therapeutics NV (AGMB) in Q3 2026, closing a stake of 698 shares — an estimated $9.06K sold.
Larson Financial Group first reported a position in AGMB in Q2 2026 and held it in 1 quarter. The position peaked at $9.06K in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.
- Larson Financial Group reported no remaining AgomAb Therapeutics NV position as of Q3 2026 after selling out during the quarter.
- Larson Financial Group sold 698 AgomAb Therapeutics NV shares in Q3 2026, an estimated $9.06K.
- Larson Financial Group first reported a position in AgomAb Therapeutics NV in Q2 2026 and held it in 1 quarter.
- Larson Financial Group's AgomAb Therapeutics NV position peaked at $9.06K in Q2 2026.
- 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.